Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Leukemia 6Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 3Lung Neoplasms 3Congenital Abnormalities 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lethal Congenital Contracture Syndrome 2 × In Situ Hybridization, Fluorescence × Clear all
NCT00740532 2010-09-02

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Istituto Clinico Humanitas

Completed
11 enrolled
Breast

Lethal Congenital Contracture Syndrome 2, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡